UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000045748
Receipt number R000052225
Scientific Title Verification of the effectiveness of a Unilateral space neglect treatment support system using MR
Date of disclosure of the study information 2021/10/14
Last modified on 2021/10/14 10:27:40

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Verification of the effectiveness of a Unilateral space neglect treatment support system using MR

Acronym

Verification of the effectiveness of a Unilateral space neglect treatment support system using MR

Scientific Title

Verification of the effectiveness of a Unilateral space neglect treatment support system using MR

Scientific Title:Acronym

Verification of the effectiveness of a Unilateral space neglect treatment support system using MR

Region

Japan


Condition

Condition

Unilateral spatial neglect

Classification by specialty

Rehabilitation medicine

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Verification of the effect of applying the developed system on the improvement of neglect symptoms in daily life

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Catherine Bergego Scale

Time of assessment
immediately before the intervention and immediately after the intervention

Key secondary outcomes

Behavioural inattention test
Slalom test
Measuring neglected areas using immersive VR

Time of assessment
immediately before the intervention and immediately after the intervention


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Device,equipment

Interventions/Control_1

Have the patient wear the HMD and present multiple holograms superimposed at shoulder height and on the ground in real space.
The patient moves around the rehabilitation space in a wheelchair or by walking while visually exploring the space. After recognizing the holograms, the patient touches the shoulder-level hologram with his/her hand or reads the text on the hologram. For holograms on the ground, touch them with the hand. This intervention will be conducted for 20 minutes a day for two weeks.

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

85 years-old >=

Gender

Male and Female

Key inclusion criteria

1.Unilateral spatial neglect patient
2.person who can perform a line erasure in the front midline without the assistance of a third party.
3. person who is not hemianopsia
4.person in the hyperacute stage or later, more than 2 weeks after the onset of illness
5. Hemiplegic stroke patients in a rehabilitation hospital

Key exclusion criteria

1. Uncontrolled heart failure
2. Acute myocardial infarction
3. Active myocarditis or pericarditis
4. Unstable angina
5. Acute systemic embolism or pulmonary embolism
6. Acute infection
7. Thrombophlebitis
8. Ventricular tachycardia or refractory ventricular arrhythmia
9. Severe ventricular outflow tract obstruction
10. Uncontrolled arterial or pulmonary hypertension
11. Those who are not capable of performing the tasks indicated in the test procedure (including breaks between tasks)
12. Those with obvious hemianopsia
13. Mini Mental State Examination (MMSE): 21 points or less (unless able to take and answer)
14. The very elderly (90 years old and above)
15. Functional Independent Measure (FIM) cognitive items: 20 points or less
16. Japan ComaScale (JCS) 3 digits or more
Exclusion criteria are determined by the attending physician

Target sample size

28


Research contact person

Name of lead principal investigator

1st name Hiroyasu
Middle name
Last name Iwata

Organization

Waseda University

Division name

Faculty science and engineering

Zip code

162-0042

Address

Room 603, Green Computing Systems Research Organization, Building 40, Waseda University, 27 Waseda-cho, Shinjuku-ku, Tokyo

TEL

03-3203-4427

Email

jubi@waseda.jp


Public contact

Name of contact person

1st name Hiroyasu
Middle name
Last name Iwata

Organization

Waseda University

Division name

Faculty science and engineering

Zip code

162-0042

Address

Room 603, GCS, Building 40, Waseda University, 27 Waseda-cho, Shinjuku-ku, Tokyo

TEL

03-3203-4427

Homepage URL


Email

jubi@waseda.jp


Sponsor or person

Institute

Waseda University

Institute

Department

Personal name



Funding Source

Organization

Waseda University

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor

medical corporation sonoda-kai sonoda-kai rehabilitation hospital

Name of secondary funder(s)



IRB Contact (For public release)

Organization

Ethics Committee of Waseda University

Address

1-104 Totsuka-cho, Shinjyuku-ku, Tokyo 169-8050

Tel

03-5272-1639

Email

rinri@list.waseda.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

医療法人社団苑田会苑田会リハビリテーション病院(東京都)


Other administrative information

Date of disclosure of the study information

2021 Year 10 Month 14 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2021 Year 10 Month 01 Day

Date of IRB


Anticipated trial start date

2021 Year 11 Month 01 Day

Last follow-up date

2026 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2021 Year 10 Month 14 Day

Last modified on

2021 Year 10 Month 14 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000052225